1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Regulatory Affairs Outsourcing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Services
6.1 Regulatory Consulting
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Legal Representation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Regulatory Writing and Publishing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Product Registration and Clinical Trial Applications
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by Company Size
7.1 Small
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Medium
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Large
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Category
8.1 Generic Drugs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Innovator Drugs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Biologic Drugs
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Biosimilars
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Medical Devices
8.5.1 Market Trends
8.5.2 Major Types
8.5.2.1 Therapeutic
8.5.2.2 Diagnostic
8.5.3 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast

9 Market Breakup by Indication
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Neurology
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cardiology
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Immunology
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast

10 Market Breakup by Stage
10.1 Preclinical
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinical
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 PMA (Post Market Authorization)
10.3.1 Market Trends
10.3.2 Market Forecast

11 Market Breakup by End User
11.1 Medical Device Companies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Pharmaceutical Companies
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Biotechnology Companies
11.3.1 Market Trends
11.3.2 Market Forecast

12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast

13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Charles River Laboratories International Inc.
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 Covance Inc (Laboratory Corporation of America Holdings)
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 SWOT Analysis
17.3.3 Freyr
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.4 ICON Plc
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 Financials
17.3.4.4 SWOT Analysis
17.3.5 Medpace Holdings Inc
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 Parexel International Corporation
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 SWOT Analysis
17.3.7 Pharmaceutical Product Development LLC
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.7.4 SWOT Analysis
17.3.8 Promedica International- A California Corporation
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.9 Wuxi AppTec Co. Ltd.
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio